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INTRODUCTION
Although diverse experimental models of liver injury, in-
cluding hepatic fibrosis and liver cirrhosis, have been estab-
lished, no model can precisely mimic the real process of hu-
man liver disease (1). Even though the results of experiments
applied on animals show similar morphology, pathologic pro-
cesses, and high repetition in comparison with the disease
process occurring in the human body, the exact mechanism
causing hepatic injury in each experimental model is not yet
known. Carbon tetrachloride (CCl4) has been used most fre-
quently in attempting to establish a liver injury model. The
hepatic P450 enzyme system converts CCl4 into trichloro-
methyl radical, which causes lipid peroxidation of polyun-
saturated fatty acids in cell membranes, and thus induces de-
struction of cell membranes and cell necrosis (2).
Studies of causative factors involving liver injury have been
performed for several years, and now we know that reactive
oxygen species (ROS), which are related to oxidative stress,
are involved in some types of liver injury (3-6). It is also
known that proinflammatory and cytotoxic cytokines play
an important role in cell injury of acute fulminant hepatitis
(7-10). Even though the relationship between oxidative stress,
cytotoxic cytokines, and liver cell injury have not been fully
understood, nuclear factor kappa B (NF- B) is considered to
play an important role in liver cell injury.
NF- B complexes exist in the cytoplasm of most resting
cells as an inactivated form of homodimer (e.g., p50-p50) or
heterodimer (e.g., p50-p65) bound to a member of the I B
family of inhibitory proteins. It is separated from I B and is
activated by many factors such as tumor necrosis factor, inter-
leukin-1, lipopolysaccharide (LPS), oxidative stress, and hu-
man immunodeficiency virus. Activated NF- B is delivered
to the nucleus and is bound to a recognition sequence of DNA
consisting of 10 base pairs. It is known that this process in-
creases the release of several cytotoxic cytokines and inflam-
matory cytotoxins (11-13).
The biosynthesis of prostaglandins (PGs) requires catalytic
action of cyclooxygenase (COX) and involves in generation
of ROS. COX has been found in two forms, COX-1 and
COX-2. The former is a constitutive enzyme which fulfills
a role under normal physiologic conditions. This synthesizes
various types of PGs in order to maintain human homeostasis.
The latter is an inducible isoform which is responsible for
production of a large amount of PGs especially when acti-
vated by stimuli, such as inflammation, cytokines, and LPS
(14-18). ROS is produced by the action of COX-2 which
converts PGG2 into PGH2 (19). The synthesis of ROS sub-
sequently activates NF- B, which has been known to contri-
bute to vicious cycles of inflammatory reactions. It has been
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NF- B Binding Activity and Cyclooxygenase-2 Expression in Persistent
CCl4-Treated Rat Liver Injury
The involvement of NF- B binding activity is known to be important in the mech-
anism of  acute liver injury and in the induction of cyclooxygenase (COX-2). This
study was performed to evaluate NF- B binding activity and the expression of
COX-2 in chronic liver injury induced by carbon tetrachloride (CCl4). Liver tissues
from Sprague - Dawley rats were collected at 1, 3, 5, and 7th week after intraperi-
toneal injection of 0.1 mL of CCl4/100 g body weight twice a week. Reactive oxy-
gen species (ROS) were measured in the postmitochondrial fraction by dichlo-
rofluorescein formation with a fluorescent probe. An electrophoretic mobility shift
assay was performed for NF- B binding activity. Western blot was performed to
measure the level of COX-1, COX-2, p65, p50, and I B proteins. ROS and NF- B
activity increased during the CCl4-induced chronic liver injury. The expression of
nuclear p65 protein and p50 protein increased compared with that of the control,
while the cytoplasmic I B protein decreased as the inflammation persisted. The
expression of COX-2 in CCl4-treated rat liver increased compared with that of the
control. It could be suggested that ROS produced by CCl4 treatment increased
NF- B binding activity and thereby COX-2 expression, and these might be impli-
cated in the progress of chronic liver damage.
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shown that various types of PGs produced by COX-2 involve
inflammation of liver cells. The level of COX-2 mRNA and
its protein is up-regulated by stimuli of TNF- . It has been
observed that the production of COX-2 mRNA and its pro-
tein is inhibited significantly by supplying NF- B inhibitor,
Ad5IKB, to HT-29 cells (20). Thus it is thought that the acti-
vation of NF- B may play an important role in the expres-
sion of COX-2.
In this regard, we investigated the NF- B binding activity
and the expression of COX-2 in chronic liver injury induced
by CCl4. CCl4 was selected because it produces a large amount
of PGs especially when activated by stimuli, such as inflam-
mation, cytokines, and LPS. ROS is produced by the action
of COX-2, thus we sought to determine whether the activa-
tion of NF- B induced by ROS contributes to liver injury
and expression of COX-2 or not. 
MATERIALS AND METHODS
Experimental Animal Preparation
After intraperitoneal injection of 0.1 mL of CCl4/100 g
body weight and 0.1 mL of mineral oil/100 g body weight
twice a week, 5 Sprague-Dawley rats were sacrificed by de-
capitation and liver tissues were removed at 1, 3, 5, and 7th
week respectively. The removed liver tissues were rinsed in
ice-cold buffer (100 mM Tris, 1 mM EDTA, 0.2 mM phenyl-
methyl-sulfonylfluoride (PMSF), 1  M pepstatin, 80 mg/L
trypsin inhibitor, 2  M leupeptin, pH 7.4) and immediate-
ly immersed in liquid nitrogen and stored at -80℃. The
control group was given 0.2 mL of mineral oil/100 g body
weight intraperitoneally.
Materials
Chemical reagents were obtained from Sigma, except as
noted. The radionucleotide [ -32]P-ATP was obtained from
Amersham (Bucks, U.K.). 2′ ,7′ -dichlorofluorescein diac-
etate (DCFDA) was from Molecular Probes, Inc. (Eugene,
OR, U.S.A.). Anti-COX-1, anti-COX2, anti-p50, anti-p65,
anti-I B antibodies were obtained from Millipore Corpo-
ration (Bedford, MA, U.S.A.). All other materials were
obtained in the highest available grade. 
Histology
After obtaining liver tissues taken from the rats which were
sacrificed at 1, 2, 5, and 7th week. Hematoxylin-eosin and
Masson-trichrome stain were applied to those tissues.
Total protein extraction
One gram of liver tissue was added to 10 mL of homoge-
nizing buffer (50 mM potassium phosphate buffer contain-
ing 1 mM EDTA, 0.5 mM PMSF, 1  M pepstatin, 80 mg/L
trypsin inhibitor, pH 7.4) and centrifuged at 900 g at 4℃
for 15 min. The supernatants were re-centrifuged at 12,000
gat 4℃for 15 min. The pellets were referred to as mitochon-
drial fractions and supernatants as postmitochodrial fractions.
The supernatants were further centrifuged at 24,000 g at 4
℃ for 1 hr. The pellets were referred to as microsomal frac-
tions and supernatants as cytosol fraction.
Nuclear extract preparation 
All solutions, tubes, and centrifuges were maintained at
0-4℃. The preparation of rat liver nuclear extracts was based
on the method by Hattori et al. (22). For extracting nuclear
proteins from cells, rat liver tissues were treated with induc-
ers including LPS and ROS, and then nuclear extracts and
cytosolic fractions were prepared by a modification of the
method by Dignam et al. (23). The nuclear extract was frozen
at -70℃ in aliquots until electrophoretic mobility shift assay
(EMSA) was done. 
The concentration of total protein in the sample was mea-
sured with bicinchoninic acids. The protein assay reagent kit
was supplied by Sigma.
Total ROS generation assay
The level of generation of ROS was measured by the method
popularized by Thomas et al. (21). Twenty-five  M of 2′ , 7′ -
dichlorofluorescein diacetate (DCFDA) was added to the liver
homogenate and then changes in fluorescence were measured
at excitation wavelength of 485 nm and emission wavelength
of 530 nm for 30 min by using a Fluorescence Plate Reader
(BIO-TEK Instruments, Inc., Winooski, U.S.A.).
Electrophoretic mobility shift assay (EMSA)
The EMSA method was used to characterize the binding
activities of NF- B transcription factors in nuclear extracts.
For EMSA the specific oligonucleotides were synthesized from
Bioneer (Daejeon, Korea). End-labeled T4 polynucleotide
kinase was obtained from Promega, and the radionucleotide
[- 32P]-ATP was obtained from Amersham. The oligonu-
cleotide used to detect the DNA-binding activites of NF- B
was as follows: 5′ -AGCTTCAGAGGGGATTTCCGAGA
GG-3′ .
Protein-DNA binding assays were performed with 10  g
of nuclear protein. Because salt can affect the binding activity,
the concentration of salt was adjusted to the same level in
all samples by adding either a low-salt or a high-salt buffer.
Nonspecfic binding was blocked by using 1  g of poly (dl-
dC)∙poly (dl-dC). The binding medium contained 4% glyc-
erol and 1.0 mM Tris/HCl (pH 7.5). In each reaction 20,000
c.p.m. of a radiolabeled probe was included. For NF- B bind-196 S.H. Kim, H.J. Chu, D.H. Kang, et al.
rabbit polyclonal anti-p65 (Santa-Cruz, 1:200), rabbit poly-
clonal anti-p50 (Santa-Cruz, 1:200) were also performed. Anti-
body labeling was detected using enhanced chemilumines-
cence (Amersham) according to the manufacturer's instruc-
tions. Pre-stained blue protein markers were used for molecu-
lar weight determinations.
Statistics
Results were analyzed statistically by Krunskal-Wallis test.
A p value less than 0.05 was considered statistically signifi-
cant.
RESULTS
Histology of liver tissue
The liver showed prominent centrilobular fatty change of
hepatocytes at 1st week (Fig. 1A) and a more developed pat-
tern at 3rd week (Fig. 1B). There were proliferation of fibrous
tissues which surrounded hepatic nodules at 5th week (Fig.
1C) and a more definite cirrhotic pattern at 7th week (Fig.
1D).
Effects of CCl4 on generation of ROS
The concentration of DCF formed by ROS (fluorescence
intensity/min/mg protein) were 76.52±3.20, 77.50±7.68,
137.64±12.12, and 163.20±6.78 at 1, 3, 5 and 7th week,
respectively. That of the control group was 60.03±2.68. ROS
generation increased significantly in CCl4-injected groups at
5th (p<0.01) and 7th week (p<0.001), compared to that of
the control group (Fig. 2).
Expression of COX-1 and COX-2
Compared to the protein expression of COX in the control
group, the protein expression of COX in CCl4-injected groups
showed decreases for COX-1 (p<0.001) (22.66 at control,
21.07 at 1st week, 19.35 at 3rd week, 19.38 at 5th week,
17.77 at 7th week). For COX-2, the CCl4-injected groups
showed statistically significant increase in the protein expres-
sion (p<0.001) (5.96 at control, 14.13 at 1st week, 15.48 at
3rd week, 17.28 at 5th week, 13.68 at 7th week), which was
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Fig. 2. Effect of CCl4 on ROS generation in postmitochondrial frac-
tion of rat liver. ROS generation was measured by dichlorofluores-
cein formation with a fluorescent probe, DCFDA. Each value rep-
resents the mean±S.E. from five rats. Statistical significance: *p<
0.05, **p<0.001 vs control rats. 
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Fig. 3. COX-1 and COX-2 expressions and densitrometric analysis in CCl4-treated rat liver. Postmitochondrial fractions from control, 1, 3,
5, and 7th week rat tissues were resolved in an 8% SDS-polyacrylamide gel electrophoresis and western blots were performed using anti-
COX-1 and anti-COX-2 antibodies. Bands were visualized by ECL procedure (Amersham).
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radical, which forms the trichloromethyl peroxyl radical (6,
24). This ROS, which leads to the process of lipid peroxida-
tion or other mechanisms of cell injury, can induce further
interactions. Rats treated with CCl4 intraperitoneally showed
fatty change of liver cells 24 hr after treatment, and severe
centriloblular necrosis 24-48 hr after treatment, which result-
ed from prominent proliferation and ballooning of the endo-
plasmic reticulum. In this study, the rat liver treated with
CCl4intraperitoneally also showed typical early extensive cen-
trilobular fatty change and a cirrhotic pattern, which is com-
posed of fibrosis and regenerative nodules several weeks later.
It is known that diverse types of cells and cytokines involved
in the inflammation participate in this kind of hepatic injury.
These cytokines, as extracelluar stimulants, regulate the genet-
ic expression of various factors and cytokines through the inter-
actions with transcription-modulating factors. It has been
considered that a kind of transcription-modulating factor,
NF- B, involves immunologic reactions and apoptosis, and
mediates acute inflammatory reactions (25). It was reported
that NF- B plays an important role in the acute liver injury
resulted from the action of CCl4 (26). The previous published
studies showed the role of NF- B in acute inflammatory reac-
tions. It is still not clear whether NF- B is involved in chron-
ic inflammatory reactions in fibrotic hepatic lesions or liver
cirrhosis.
We evaluated the generation of ROS and the changes of
NF- B-binding activity in cases of fibrotic liver and cirrhotic
liver caused by CCl4-induced persistent hepatic inflamma-
tion. We observed the increase of the ROS level in the CCl4-
treated group compared to that of the control group. The
level of NF- B-binding activity also increased, and the pat-
tern of the increase was similar to that of ROS. Thus it can
be concluded that the activation of NF- B may play an im-
portant role not only in the process of acute liver injury but
also in the process of cirrhotic changes.
NF- B complexes exist in the cytoplasm as a homodimer
(e.g., p50-p50) or heterodimer (e.g., p50-p65) bound to a
member of the I B, which mainly acts as an inhibitor of NF-
B. It is known that the NF- B complexes are activated by
phosphorylation and ubiquitination. After the degradation
of the I B component, NF- B migrates into the nucleus
where transactivation is induced by specific DNA binding
(27, 28). The signals, which cause the phophorylation and
ubiquitination, and follow the degradation of the I B com-
ponent, have been known to come from tumor necrosis fac-
tor, interleukin-1, lipopolysaccharide, oxidative stress, and
human immunodeficiency virus (29). 
The western blot analysis of the nuclear proteins revealed
an increase in the shifts of p50 and p65 into the nuclei in the
groups treated with CCl4 compared to the control group. The
shifts of p50 and p65 into the nuclei tended to increase in
proportion to the duration of inflammation. The binding
activity of NF- B is dependent on whether NF- B is acti-
vated or not. I -B- modulates the activity of NF- B through
mechanisms such as phosphorylation, ubiquitination, and
proteasome-mediated degradation.
In this study, the expression of I -B- decreased in the
group treated with CCl4 compared to the control group. This
tended to be proportional to the duration of the inflamma-
tion. This suggests that the activation of NF- B plays an im-
portant role not only in the case of acute liver injury but also
in the case of chronic persistent liver injury.
The main action of NF- B in liver injury is to mediate the
release of cytotoxic cytokines and inflammatory cytotoxins.
Over 100 target genes for NF- B have been identified dur-
ing the past few years. One of them is the COX-2 gene. It
is known that COX-2 is responsible for inflammatory reac-
tion, carcinogenesis of hepatocellular carcinoma (30, 31), and
portal hypertension. Portal hypertension in rats, which was
induced by ligation of the portal vein, was improved with-
out gastric mucosal injury by giving the selective COX-2
antagonist NS-398 (32). According to this report, it seems
that COX-2 is related to portal hypertension. The overex-
pressed COX-2, synthesis of which is up-regulated by inflam-
matory stimuli or hyperoxidation of lipid, induces synthesis
of PG, which causes liver injury (33). COX-2 catalyzes the
conversion of PGG2 to PGH2, which produces ROS (19).
ROS activates NF- B, which in turn leads to a vicious cycle
of inflammation. It has not been made clear what mechanism
is involved in the COX-2 expression. It is known, however,
that COX-2 is one of the target genes for NF- B and the
Kupffer cells are mainly involved in the expression of COX-
2 gene (33). 
Fig. 6. Cytoplasmic I B- protein levels  and densitrometric analy-
sis in CCl4-treated rat liver. Cytoplasmic extracts from control, 1,
3, 5, and 7th week rat tissues were resolved in a 12% SDS-poly-
acrylamide gel electrophoresis and western blots were performed
using anti-I B antibody. Bands were visualized by ECL proce-
dure.
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